Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 401-280-0 | CAS number: 91273-04-0 CM 23-376; REOMET 30
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May - August 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- not applicable
- Principles of method if other than guideline:
- Meets the principles of OECD guideline 474 with the following restriction: only 1000 immature erythrocytes per animal were counted.
- GLP compliance:
- no
- Remarks:
- but GLP like quality assurance
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 1-(N,N-bis(2-ethylhexyl)aminomethyl)-1,2,4-triazole
- EC Number:
- 401-280-0
- EC Name:
- 1-(N,N-bis(2-ethylhexyl)aminomethyl)-1,2,4-triazole
- Cas Number:
- 91273-04-0
- Molecular formula:
- C19 H38 N4
- IUPAC Name:
- bis(2-ethylhexyl)[(1H-1,2,4-triazol-1-yl)methyl]amine
- Details on test material:
- - Analytical purity: Commercial grade
Constituent 1
Test animals
- Species:
- hamster, Chinese
- Strain:
- other: random outbred strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY Tierfarm, Sisseln.
- Age at study initiation: female 6-10 weeks, male 4-9 weeks
- Weight at study initiation: female 21-32 g, male 21-38 g (tolerability test), female 20-31 g, male 21-34 g (mutagenicity test)
- Water: ad libitum
- Diet: standard diet, NAFAG No.924
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-23°C
- Humidity (%): 46-50%
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Vehicle used: aqueous solution of sodium carboxymethylcellulose (0.5%)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: 5000 mg/kg test item in 20 mL/kg 0.5% aqueous solution of sodium carboxymethylcellulose.
- Frequency of treatment:
- Single application
- Post exposure period:
- 16, 24 and 48h after application
Doses / concentrations
- Dose / conc.:
- 5 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- In the tolerability test: 2 males and 2 females
In the mutagenicity test: 24 males and 24 females in each treatment group and in the negative control group (8 males and 8 females per sampling time).
8 males and 8 females in the positive control group. - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide (64 mg/kg)
Examinations
- Tissues and cell types examined:
- Bone marrow; erythrocytes
- Details of tissue and slide preparation:
- SAMPLING TIME: 16, 24 and 48 h after application
DETAILS OF SLIDE PREPARATION: Bone marrow was harvested from the shafts of both femurs. In a siliconized pipette filled with approx. 0.5 µL rat serum the bone marrow was drawn up. Small drops of the mixture were transferred on the end of a slide, spread out by pulling it behind a polished cover glass and the preparations were air-dried. Three hours later, the slides were stained in undiluted May-Grünwald solution for 2 min then in May-Grünwald solution/water 1/1 and then in Giemsa's, 40% .
METHOD OF ANALYSIS:1000 polychromatic erythrocytes each were scored for the incidence of micronuclei per animal. The ratio of polychromatic to normochromatic erythrocytes was determined for each animal by counting a total of 1000 erythrocytes. - Statistics:
- The significance of difference was assessed by X2-test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 5000 mg/kg bw
- Mortality: none
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: The bone marrow smears from animals treated with the dose of 5000 mg/kg of the test item showed no statistically significant increase (p>0,05) in the number of micronucleated polychromatic erythrocytes compared to the negative control animals at all three sampling times.
- Ratio of PCE/NCE: Ratio was not influenced by the test item.
- The respective "positive control" experiments with cyclophosphamide (64 mg/kg) yielded an average of 4.15% polychromatic erythrocytes with micronuclei. This is significantly different from the controls (0.15%) treated with the vehicle (0.5% CMC) alone.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Under the conditions of this experiment, no evidence of mutagenic effects was obtained in Chinese hamsters treated with the test substance. - Executive summary:
A micronucleus experiment was performed to evaluate any mutagenic effect of the test article on polychromatic erythrocytes in bone marrow cells in vivo. The test article in 0.5% carboxymethyl cellulose was administered orally to groups of 24 female and 24 male animals each in the negative and in the 5000 mg/kg dose group. The positive control group consisted of 8 female and 8 male animals and was treated with Cyclophosphamide (64 mg/kg). Treatment consisted of a single application. 16, 24 and 48h after application 8 female and 8 male animals per group and sampling time were sacrificed by dislocation of the cervical vertebrae. From the bone marrow smears were made. The bone marrow smears from animals treated with the dose of 5000 mg/kg showed no statistically significant increase (p>0,05) in the number of micronucleated polychromatic erythrocytes compared to the negative control animals at all three sampling times. The respective "positive control" experiments with cyclophosphamide yielded an average of 4.15% polychromaticerythrocytes with micronuclei. This is significantly different from the controls (0.15%) treated with the vehicle (0.5% CMC) alone. It is concluded that under the conditions of this experiment, no evidence of mutagenic effects was obtained in Chinese hamsters treated with the test substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.